PATENT CLAIM ANALYSIS

Application Number: 15892295
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "044000"]

Abstract:
Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.

Claim (Index 78):
A polynucleotide according to  claim 77 , wherein the amino acid residue 167 is mutated to a polar or non-polar amino acid.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 88.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14214522', '14214448', '15516012', '10457604', '15211586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7391691377690651
- 35 USC 102 Novelty (BERT): 0.7084257303062207
- Combined Prediction Score: 0.7360947970227807
- Mean Citation Score: 426.671468
- Max Citation Score: 831.2875
- Similarity Product: 707.0060445562005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test